Skip to content
IV Injection Allopathic

Doxerol 4 mcg/2 ml iv injection

Generic: Doxercalciferol

Company: ACI Limited. Prices are as listed on BestinMeds; your pharmacy price may differ.

Strength4 mcg/2 ml
PackNot listed yet

Reviewed by: not listed yet. Source: not listed yet.

Last updated September 25, 2025.

Compare

Same generic, same strength

Sorted by price per iv injection. Ask your pharmacist before you switch brands.

Doxercalciferol 4 mcg/2 ml iv injections

Prices as listed on BestinMeds.

No price is listed for this strength yet.

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250
Medicine guide

About this medicine

What this medicine is for, how to take it, and what to watch for.

Read the full Doxercalciferol guide

Indications

Doxercalciferol injection is indicated for the treatment of secondary hyperparathyroidism in adult patients with CKD on dialysis.

Dosage and administration

Route of administration: Doxercalciferol injection should be administered intravenously. Ensure serum calcium is not above the upper limit of normal before initiating treatment with Doxercalciferol injection. Administration instructions: Administer Doxercalciferol injection intravenously as a bolus dose at the end of dialysis. Inspect Doxercalciferol injection visually prior to administration; the solution should appear clear and colorless. Do not use if the solution is not clear or particles are present. Dosage recommendations: Initiate Doxercalciferol injection at a dose of 4 meg given by bolus intravenous administration three times weekly at the end of dialysis (no more frequently than every other day). Target the maintenance dose of Doxercalciferol to intact parathyroid hormone (PTH) levels within the desired therapeutic range and serum calcium within normal limits. Monitor serum calcium, phosphorus and intact PTH levels weekly after initiation of therapy or dose adjustment. Titrate the dose of Doxercalciferol injection based on intact PTH. The dose may be increased at 8-week intervals by 1 meg to 2 meg if intact PTH is not lowered by 50% and fails to reach the target range. The maximum dose is 18 meg weekly. Prior to raising the dose, ensure serum calcium is within normal limits. Suspend or decrease the dose if intact PTH is persistently and abnormally low to reduce the risk of adynamic bone disease or if serum calcium is consistently above the normal range to reduce the risk of hypercalcemia. If suspended, the drug should be restarted one week later at a dose that is at least 1 meg lower. Use in children and adolescents: The safety and effectiveness of doxercalciferol in pediatric patients have not been established.

Side effects

Most common side effects are infection/bacterial infection/viral infection, constipation, rhinitis, anemia, cough, dyspnea, paresthesia, asthenia, insomnia, hypertonia and angina pectoris.

Precautions and warnings

Hypercalcemia can occur during treatment with doxercalciferol and can lead to cardiac arrhythmias and seizures. Severe hypercalcemia may require emergency attention. Monitor serum calcium prior to initiation and during treatment and adjust dose accordingly. Anaphylaxis, with symptoms of angioedema, hypotension, unresponsiveness, chest discomfort, shortness of breath and cardiopulmonary arrest, has been reported in hemodialysis patients after administration of doxercalciferol. Monitor patients upon treatment initiation for hypersensitivity reactions. Should a hypersensitivity reaction occur, discontinue and treat if indicated. Adynamic bone disease may develop and increase risk of fractures if intact PTH levels are suppressed to abnormally low levels. Monitor intact PTH levels to avoid oversuppression and adjust dose if needed. More frequent monitoring of intact PTH, calcium and phosphorus levels should be done in patients with hepatic impairment.

Pregnancy and lactation

The limited available data with doxercalciferol in pregnant women are insufficient to identify a drug-associated risk for major birth defects, miscarriage or adverse maternal or fetal outcomes. The developmental and health benefits of breastfeeding should be considered along with the mother’s clinical need for doxercalciferol and any potential adverse effects on the breastfed infant from doxercalciferol or from the underlying maternal condition.

Clinical details

BestinMeds shares medicine information to help you compare. It does not replace advice from your doctor or pharmacist.

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250